Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growth

Abstract Prostate cancer (PCa) growth depends on de novo lipogenesis controlled by the mitochondrial pyruvate dehydrogenase complex (PDC). In this study, we identify lysine methyltransferase (KMT)9 as a regulator of PDC activity. KMT9 is localized in mitochondria of PCa cells, but not in mitochondri...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanhan Jia, Sheng Wang, Sylvia Urban, Judith M. Müller, Manuela Sum, Qing Wang, Helena Bauer, Uwe Schulte, Heike Rampelt, Nikolaus Pfanner, Katrin M. Schüle, Axel Imhof, Ignasi Forné, Christopher Berlin, August Sigle, Christian Gratzke, Holger Greschik, Eric Metzger, Roland Schüle
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-56492-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571532918915072
author Yanhan Jia
Sheng Wang
Sylvia Urban
Judith M. Müller
Manuela Sum
Qing Wang
Helena Bauer
Uwe Schulte
Heike Rampelt
Nikolaus Pfanner
Katrin M. Schüle
Axel Imhof
Ignasi Forné
Christopher Berlin
August Sigle
Christian Gratzke
Holger Greschik
Eric Metzger
Roland Schüle
author_facet Yanhan Jia
Sheng Wang
Sylvia Urban
Judith M. Müller
Manuela Sum
Qing Wang
Helena Bauer
Uwe Schulte
Heike Rampelt
Nikolaus Pfanner
Katrin M. Schüle
Axel Imhof
Ignasi Forné
Christopher Berlin
August Sigle
Christian Gratzke
Holger Greschik
Eric Metzger
Roland Schüle
author_sort Yanhan Jia
collection DOAJ
description Abstract Prostate cancer (PCa) growth depends on de novo lipogenesis controlled by the mitochondrial pyruvate dehydrogenase complex (PDC). In this study, we identify lysine methyltransferase (KMT)9 as a regulator of PDC activity. KMT9 is localized in mitochondria of PCa cells, but not in mitochondria of other tumor cell types. Mitochondrial KMT9 regulates PDC activity by monomethylation of its subunit dihydrolipoamide transacetylase (DLAT) at lysine 596. Depletion of KMT9 compromises PDC activity, de novo lipogenesis, and PCa cell proliferation, both in vitro and in a PCa mouse model. Finally, in human patients, levels of mitochondrial KMT9 and DLAT K596me1 correlate with Gleason grade. Together, we present a mechanism of PDC regulation and an example of a histone methyltransferase with nuclear and mitochondrial functions. The dependency of PCa cells on mitochondrial KMT9 allows to develop therapeutic strategies to selectively fight PCa.
format Article
id doaj-art-98fbab92ad454a78befd48923b77c4ce
institution Kabale University
issn 2041-1723
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-98fbab92ad454a78befd48923b77c4ce2025-02-02T12:31:55ZengNature PortfolioNature Communications2041-17232025-01-0116111410.1038/s41467-025-56492-8Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growthYanhan Jia0Sheng Wang1Sylvia Urban2Judith M. Müller3Manuela Sum4Qing Wang5Helena Bauer6Uwe Schulte7Heike Rampelt8Nikolaus Pfanner9Katrin M. Schüle10Axel Imhof11Ignasi Forné12Christopher Berlin13August Sigle14Christian Gratzke15Holger Greschik16Eric Metzger17Roland Schüle18Klinik für Urologie und Zentrale Klinische Forschung, Klinikum der Universität FreiburgKlinik für Urologie und Zentrale Klinische Forschung, Klinikum der Universität FreiburgKlinik für Urologie und Zentrale Klinische Forschung, Klinikum der Universität FreiburgKlinik für Urologie und Zentrale Klinische Forschung, Klinikum der Universität FreiburgKlinik für Urologie und Zentrale Klinische Forschung, Klinikum der Universität FreiburgComplete Omics Inc.Klinik für Urologie und Zentrale Klinische Forschung, Klinikum der Universität FreiburgInstitute of Physiology II, Faculty of Medicine, University of FreiburgCIBSS Centre of Biological Signalling Studies, University of FreiburgCIBSS Centre of Biological Signalling Studies, University of FreiburgInstitute of Experimental and Clinical Pharmacology and Toxicology, Faculty of Medicine, University of FreiburgInstitute Biomedical Center, Protein Analysis Unit, Faculty of Medicine, Ludwig-Maximilians-Universität MünchenInstitute Biomedical Center, Protein Analysis Unit, Faculty of Medicine, Ludwig-Maximilians-Universität MünchenDepartment of General and Visceral Surgery, Faculty of Medicine, University of FreiburgKlinik für Urologie und Zentrale Klinische Forschung, Klinikum der Universität FreiburgKlinik für Urologie und Zentrale Klinische Forschung, Klinikum der Universität FreiburgKlinik für Urologie und Zentrale Klinische Forschung, Klinikum der Universität FreiburgKlinik für Urologie und Zentrale Klinische Forschung, Klinikum der Universität FreiburgKlinik für Urologie und Zentrale Klinische Forschung, Klinikum der Universität FreiburgAbstract Prostate cancer (PCa) growth depends on de novo lipogenesis controlled by the mitochondrial pyruvate dehydrogenase complex (PDC). In this study, we identify lysine methyltransferase (KMT)9 as a regulator of PDC activity. KMT9 is localized in mitochondria of PCa cells, but not in mitochondria of other tumor cell types. Mitochondrial KMT9 regulates PDC activity by monomethylation of its subunit dihydrolipoamide transacetylase (DLAT) at lysine 596. Depletion of KMT9 compromises PDC activity, de novo lipogenesis, and PCa cell proliferation, both in vitro and in a PCa mouse model. Finally, in human patients, levels of mitochondrial KMT9 and DLAT K596me1 correlate with Gleason grade. Together, we present a mechanism of PDC regulation and an example of a histone methyltransferase with nuclear and mitochondrial functions. The dependency of PCa cells on mitochondrial KMT9 allows to develop therapeutic strategies to selectively fight PCa.https://doi.org/10.1038/s41467-025-56492-8
spellingShingle Yanhan Jia
Sheng Wang
Sylvia Urban
Judith M. Müller
Manuela Sum
Qing Wang
Helena Bauer
Uwe Schulte
Heike Rampelt
Nikolaus Pfanner
Katrin M. Schüle
Axel Imhof
Ignasi Forné
Christopher Berlin
August Sigle
Christian Gratzke
Holger Greschik
Eric Metzger
Roland Schüle
Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growth
Nature Communications
title Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growth
title_full Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growth
title_fullStr Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growth
title_full_unstemmed Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growth
title_short Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growth
title_sort mitochondrial kmt9 methylates dlat to control pyruvate dehydrogenase activity and prostate cancer growth
url https://doi.org/10.1038/s41467-025-56492-8
work_keys_str_mv AT yanhanjia mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth
AT shengwang mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth
AT sylviaurban mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth
AT judithmmuller mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth
AT manuelasum mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth
AT qingwang mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth
AT helenabauer mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth
AT uweschulte mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth
AT heikerampelt mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth
AT nikolauspfanner mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth
AT katrinmschule mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth
AT axelimhof mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth
AT ignasiforne mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth
AT christopherberlin mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth
AT augustsigle mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth
AT christiangratzke mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth
AT holgergreschik mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth
AT ericmetzger mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth
AT rolandschule mitochondrialkmt9methylatesdlattocontrolpyruvatedehydrogenaseactivityandprostatecancergrowth